跳到正文
原文
Nature 健康护理主题·· 2026-10-07AI 评分35

伊朗—阿富汗边境农村社区HBV暴露、HBsAg阳性与抗-HDV血清流行率:一项社区横断面研究

HBV exposure, HBsAg positivity, and anti-HDV seroprevalence in rural communities along the Iran–Afghanistan border: a community-based cross-sectional study

AI 导读

伊朗—阿富汗边境农村社区横断面血清调查显示,489名可评估居民抗-HBc血清阳性率为23.3%(114/489),>30岁人群为45.3%。抗-HBc阳性者中HBsAg阳性率为36.8%(42/114),HBsAg阳性者抗-HDV血清阳性率为12.2%(5/41)。年龄>30岁与抗-HBc阳性相关(调整OR 19.36,95%CI 10.34–38.89)。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Hepatitis B virus (HBV) exposure and hepatitis D virus (HDV) antibody prevalence remain incompletely characterized in rural eastern Iran. We estimated anti-HBc seroprevalence, conditional HBsAg positivity, and anti-HDV seropositivity in three border villages. We conducted a community-based cross-sectional serosurvey with census-targeted recruitment in three villages of Nehbandan County, South Khorasan Province, Iran, during May–June 2024. All evaluable specimens were tested for total anti-HBc. HBsAg was measured only in anti-HBc-positive specimens, and anti-HDV was measured among participants with a final HBsAg-positive classification. Correlates of anti-HBc positivity were estimated using Firth penalized logistic regression. Of 842 residents, 494 participated (58.7%), and 489 had an evaluable anti-HBc result. Anti-HBc seroprevalence was 23.3% (114/489; 95% CI 19.6%–27.3%), including 5.3% at age ≤ 30 years and 45.3% at age > 30 years. In the primary model, age > 30 years (adjusted OR 19.36, 95% CI 10.34–38.89), Khvajeh Monji Kuh residence (4.50, 2.46–8.46), and family history of HBV (2.52, 1.12–5.62) were associated with anti-HBc positivity. The family-history confidence interval included 1 after adding education and occupation. Among anti-HBc-positive participants, 42/114 (36.8%, exact 95% CI 28.0%–46.4%) were HBsAg positive. Anti-HDV seropositivity was 5/41 (12.2%, 4.1%–26.2%). Fifteen HBsAg-positive participants initiated treatment after specialist assessment. HBV exposure was concentrated among older participants. Village comparisons were descriptive because participation differed substantially, and family-history estimates were sensitive to model specification. Birth-cohort analyses did not establish an additional cohort association beyond flexible adjustment for attained age.Staged testing prevented estimation of population HBsAg prevalence. Anti-HDV seropositivity supports antibody screening followed by HDV RNA testing to establish active infection.

Acknowledgements

The authors gratefully acknowledge the residents of Khvajeh Do Chahi, Khvajeh Monji Kuh, and Kalateh Habib for their participation and cooperation. We also thank the staff of the Infectious Diseases Research Center and the local healthcare workers in Nehbandan County for their assistance with fieldwork, laboratory coordination, and participant follow-up.

Author information

Authors and Affiliations

  1. Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

    Parvin Askari, Davod Javanmard, Motahareh Mahi-Birjand, Effat Alemzadeh, Abdol Sattar Pagheh, Ghodsiyeh Azarkar, Soudabeh Eshaghi, Arash Ziaee & Masood Ziaee

  2. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Arezou Khosrojerdi

Authors

  1. Parvin Askari
  2. Davod Javanmard
  3. Motahareh Mahi-Birjand
  4. Effat Alemzadeh
  5. Arezou Khosrojerdi
  6. Abdol Sattar Pagheh
  7. Ghodsiyeh Azarkar
  8. Soudabeh Eshaghi
  9. Arash Ziaee
  10. Masood Ziaee

Corresponding author

Correspondence to Masood Ziaee.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study protocol was approved by the Research Ethics Committee of Birjand University of Medical Sciences, Birjand, Iran, under approval code IR.BUMS.REC.1402.526. Participation was voluntary. Adult participants provided written informed consent before interview and blood sampling. For participating children, a parent or guardian provided consent at enrollment. No separate written parental-consent form, formal child-assent procedure, or predefined age threshold was used. These procedures were described in the protocol reviewed and approved by the Research Ethics Committee. All collected information was treated as confidential, and all methods were carried out in accordance with relevant guidelines and regulations.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Askari, P., Javanmard, D., Mahi-Birjand, M. et al. HBV exposure, HBsAg positivity, and anti-HDV seroprevalence in rural communities along the Iran–Afghanistan border: a community-based cross-sectional study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-73821-z

Download citation

  • Received: 23 April 2026

  • Accepted: 25 September 2026

  • Published: 07 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-73821-z

Keywords

来源:Nature 健康护理主题 · nature.com